| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/11/2009 | WO2009073115A1 Combination vegfr2 therapy with mtor inhibitors |
| 06/11/2009 | WO2009073083A1 Methods of using deomperidone to terminate acute episodes of cardiac arrhythmia, to restore normal sinus rhythm |
| 06/11/2009 | WO2009073056A1 Novel tetracycline derivatives as antibacterial agents |
| 06/11/2009 | WO2009073051A1 Use of rr/sr-ractopamine |
| 06/11/2009 | WO2009073050A2 Use of curcumin to block brain tumor formation in vivo |
| 06/11/2009 | WO2009073012A1 Method for applying a polymer coating to an internal surface of a container |
| 06/11/2009 | WO2009072967A1 Triazolo [4,5-d] pyrimidine compounds for treatment of abdominal aortic aneurysms |
| 06/11/2009 | WO2009072915A1 New salts and crystal forms |
| 06/11/2009 | WO2009072808A2 Cosmetic composition for body slimming containing 2-cyclopentene-1-one oxime derivatives |
| 06/11/2009 | WO2009072807A2 Pharmaceutical composition for preventing or treating fat metabolism-related diseases containing 2-cyclopentene-1-one oxime derivatives |
| 06/11/2009 | WO2009072649A1 4-arylphenyl derivative |
| 06/11/2009 | WO2009072643A1 Nitrogen-containing heterocyclic compound and use thereof |
| 06/11/2009 | WO2009072635A1 Method for amplifying hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | WO2009072629A1 Skin external preparation |
| 06/11/2009 | WO2009072625A1 Amplification method for hematopoietic stem cells with heterocyclic compound |
| 06/11/2009 | WO2009072621A1 Substituted dihydroazole compound and pest control agent |
| 06/11/2009 | WO2009072594A1 Periodontal bacterial growth inhibitor, oral hygiene product, and food and drink |
| 06/11/2009 | WO2009072581A1 Lactam compound or salt thereof, and ppar activator |
| 06/11/2009 | WO2009072578A1 Bone resorption inhibitor |
| 06/11/2009 | WO2009072576A1 Bone formation stimulator |
| 06/11/2009 | WO2009072267A1 Abcg2 inhibitor |
| 06/11/2009 | WO2009072132A2 Beta glycolipids for the treatment of calcification related degenerative disorders |
| 06/11/2009 | WO2009072120A1 Use of zinc in combination with chemotherapy for treating cancer |
| 06/11/2009 | WO2009072097A1 Antimicrobial compositions comprising fatty acids and milk proteins |
| 06/11/2009 | WO2009072086A1 Methods of and combination therapies for treating or delaying the onset of dyskinesia |
| 06/11/2009 | WO2009072004A2 Compositions and methods for effecting nad+ levels using a nicotinamide phosphoribosyl transferase inhibitor |
| 06/11/2009 | WO2009071993A2 Pharmaceutical compositon for cleansing of the bowel |
| 06/11/2009 | WO2009071988A1 Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide |
| 06/11/2009 | WO2009071959A2 Composition containing itraconazole |
| 06/11/2009 | WO2009071954A1 Effervescent tablets and effervescent granules containing carnitine tartrate |
| 06/11/2009 | WO2009071947A2 Potassium ion channel modulators and uses thereof |
| 06/11/2009 | WO2009071906A1 Derivatives of 1-[(imidazolidin-2-yl)imino)]indazole |
| 06/11/2009 | WO2009071905A2 Use of thiolatocobalamins as regulators/selective promoters of inducible and constitutive nitric oxide synthases |
| 06/11/2009 | WO2009071901A1 A substituted thieno-pyridinone kinase inhibitor |
| 06/11/2009 | WO2009071895A1 Fused thiazole and thiophene derivatives as kinase inhibitors |
| 06/11/2009 | WO2009071890A1 Tricyclic kinase inhibitors |
| 06/11/2009 | WO2009071850A2 Nanoparticles of therapeutic agents having low water solubility |
| 06/11/2009 | WO2009071804A2 Use of phytoecdysones in the preparation of a composition for acting on metabolic syndrome |
| 06/11/2009 | WO2009071753A1 4-phenyl-1,3-thiazole and 4-phenyl-1,3-oxazole derivatives as cannabinoid receptor ligands |
| 06/11/2009 | WO2009071731A1 Use of an ionic complex of gentamicin : aot for the treatment of brucellosis |
| 06/11/2009 | WO2009071730A1 Composition comprising gentamicin, an anionic surfactant and a copolymer |
| 06/11/2009 | WO2009071725A2 Use of valproate for the treatment of fear and phobia in subjects with alzheimer's disease |
| 06/11/2009 | WO2009071707A1 Novel compounds useful for the treatment of degenerative & inflammatory diseases |
| 06/11/2009 | WO2009071706A1 Pyrazolepyrimidine compounds useful for the treatment of degenerative & inflammatory diseases |
| 06/11/2009 | WO2009071705A1 Pyrazolepyrimidine compounds useful for the treatment of degenerative & inflammatory diseases |
| 06/11/2009 | WO2009071701A1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases |
| 06/11/2009 | WO2009071697A1 Biodegradable single-phase cohesive hydrogel |
| 06/11/2009 | WO2009071689A2 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | WO2009071687A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 06/11/2009 | WO2009071681A2 Rna antagonist compounds for the modulation of bcl-2 |
| 06/11/2009 | WO2009071677A1 New compounds iii |
| 06/11/2009 | WO2009071660A1 Use of protease nexin 1 inhibitors to reduce metastasis |
| 06/11/2009 | WO2009071658A1 Piperazines as anti-obesity agents |
| 06/11/2009 | WO2009071657A1 Tricyclic triazolic compounds |
| 06/11/2009 | WO2009071631A2 Dibenzoazepine and dibenzooxazepine trpa1 agonists |
| 06/11/2009 | WO2009071625A1 Mequitazine for treating or preventing pathologies involving histamine h4 receptors |
| 06/11/2009 | WO2009071620A1 Use of 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives in leukemia management |
| 06/11/2009 | WO2009071607A2 Ergoline derivatives as selective radical scavengers for neurons |
| 06/11/2009 | WO2009071606A1 Organic compounds |
| 06/11/2009 | WO2009071594A1 Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders |
| 06/11/2009 | WO2009071586A2 3-(2,2,2-trimethylhydrazinium) propionate salts for treating ischemic heart disease |
| 06/11/2009 | WO2009071585A1 Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate |
| 06/11/2009 | WO2009071577A1 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 06/11/2009 | WO2009071576A1 5-aryl-1,3,4-oxadiazole-2-amines as nicotinic acetylcholine receptor agonists |
| 06/11/2009 | WO2009071564A1 Pharmaceutical composition for treating malaria |
| 06/11/2009 | WO2009071553A1 New therapeutic uses of dual molecules containing a peroxide derivative |
| 06/11/2009 | WO2009071535A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 06/11/2009 | WO2009071519A1 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 06/11/2009 | WO2009071509A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 06/11/2009 | WO2009071504A1 2,6-disubstituted pyridines as soluble guanylate cyclase activators |
| 06/11/2009 | WO2009071500A2 Organic compounds |
| 06/11/2009 | WO2009071483A1 1- (indaz0l-5-yl) -ureas as diacylglycerol acyltransferase inhibitors |
| 06/11/2009 | WO2009071480A2 Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors |
| 06/11/2009 | WO2009071477A1 Isoxazolo-pyridazine derivatives |
| 06/11/2009 | WO2009071476A1 Isoxazolo-pyridine derivatives |
| 06/11/2009 | WO2009071464A1 Isoxazolo-pyrazine derivatives |
| 06/11/2009 | WO2009071405A1 Megestrol acetate for reducing the mortality and/or improving quality of life in cancer patients |
| 06/11/2009 | WO2009071310A1 Crystalline modifications of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl -propyl)-phenol |
| 06/11/2009 | WO2009071308A1 Pharmaceutical containing a hormone combination having a contraceptive effect and an insulin sensitizer |
| 06/11/2009 | WO2009071277A1 Novel nutraceutical compositions containing stevia extract or stevia extract constituents and uses thereof |
| 06/11/2009 | WO2009071252A1 Nonsteroidal progesterone receptor modulators |
| 06/11/2009 | WO2009071213A1 Anti-glycation properties of asicatic acid and madecassic acid |
| 06/11/2009 | WO2009071161A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 06/11/2009 | WO2009071101A1 N-modified aminoguanidine derivatives |
| 06/11/2009 | WO2009071099A1 Elevation of the plasma hdl-cholesterol level |
| 06/11/2009 | WO2009071096A2 Combination of medical and physical cooling treatment of ischemic effects |
| 06/11/2009 | WO2009071095A2 Prevention of hyperthermia subsequent to hypothermia treatment of ischemia |
| 06/11/2009 | WO2009070974A1 Therapeutic composition containing amlodipine nicotinate and statins |
| 06/11/2009 | WO2009070973A1 Therapeutic composition containing amlodipine nicotinate and sartans |
| 06/11/2009 | WO2009070957A1 Inhibitor of the interaction between blys and ngr and use thereof |
| 06/11/2009 | WO2009070921A1 Antimelancholic medicine prepared with jujube camp materials |
| 06/11/2009 | WO2009070917A1 An oral pharmaceutical composition for treating barythymia |
| 06/11/2009 | WO2009070873A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity |
| 06/11/2009 | WO2009070869A1 Renin inhibitors |
| 06/11/2009 | WO2009070847A1 Compounds for therapy and diagnosis |
| 06/11/2009 | WO2009070829A1 Non-aqueous oil-based fentanyl compositions for transmucosal administration |
| 06/11/2009 | WO2009055742A3 Delivery of active agents |
| 06/11/2009 | WO2009055740A3 Method of preventing adverse effects by glp-1 |
| 06/11/2009 | WO2009055629A3 Cyclohexeneamide derivatives and their use as trpv1 antagonist |
| 06/11/2009 | WO2009055437A3 (1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholine receptors, useful for the treatment of disease |